DJIA 16,501.65 -12.72 -0.08%
NASDAQ 4,126.97 0.00 0.00%
S&P 500 1,875.39 -4.16 -0.22%
market minute promo

14.61 -0.30 (-2.01%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

VNDA $14.61 -2.01%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $14.80
Previous Close $14.91
Daily Range $14.30 - $15.08
52-Week Range $4.63 - $19.25
Market Cap $489.5M
P/E Ratio -22.25
Dividend (Yield) $0.00 (0.0%)
Volume 963,692
Average Daily Volume 1,383,815
Current FY EPS -$1.29





Vanda Pharmaceuticals, Inc. (VNDA) Description

A biopharmaceutical company focused on the development and commercialization of clinical-stage drug candidates, with exclusive worldwide commercial rights to three product candidates in clinical development for various central nervous system disorders. Website:

News & Commentary Rss Feed

Vanda Pharmaceuticals (VNDA) Soars: Stock Adds 9.6% in Session - Tale of the Tape

Vanda Pharmaceuticals (VNDA) In A Perilous Reversal

Chen Lin's Perfect Biotech Market Prescription: Buy Low, Sell High

Vanda Reports Wider-than-Expected Loss - Analyst Blog

Vanda Pharmaceuticals Management Discusses Q4 2013 Results - Earnings Call Transcript

Vanda Pharmaceuticals' Q4 Loss Widens on Higher Expenses

Vanda Pharmaceuticals reduced R&D expenses by 41%, but a tripling in SG&A expenses combined with modest Fanapt growth caused its loss to widen by 20%.

Trade-Ideas: Vanda Pharmaceuticals (VNDA) Is Today's "Perilous Reversal" Stock

Short Interest Drops 15.5% For VNDA

Baker Brothers' Holding Cerus Flying Under The Radar With Catalyst Upcoming

3 Horrendous Health-Care Stocks This Week

Which health-care stocks had as lousy of a week as Broncos fans? Here are 3 big losers from the past few days.

See More VNDA News...

VNDA's Top Competitors

VNDA $14.61 (-2.01%)
Current stock: VNDA
AMGN $113.32 (-5.02%)
Current stock: AMGN
GILD $73.86 (1.37%)
Current stock: GILD
BIIB $306.75 (0.18%)
Current stock: BIIB